Literature DB >> 19501947

[Asbestos-related diseases in a population near a fibrous cement factory].

Josep Tarrés1, Rafael Abós-Herràndiz, Constança Albertí, Xavier Martínez-Artés, Magdalena Rosell-Murphy, Isabel García-Allas, Illona Krier, Emilia Castro, Gloria Cantarell, Miguel Gallego, Ramón Orriols.   

Abstract

BACKGROUND AND
OBJECTIVE: The first fibrous cement factory in Spain was set up in Cerdanyola, Barcelona, in 1907 and was a source of pollution there until it was closed in 1997. The aim of this study was to determine the clinical and epidemiologic characteristics of the population with by asbestos-related diseases who had worked in the factory and/or lived in the vicinity.
MATERIAL AND METHODS: We retrospectively collected information available on patients with asbestos-related diseases who at the time of diagnosis had resided in the area near the fibrous cement factory. Information was obtained from the medical records of the primary care centers of the 12 surrounding towns and the sole referral hospital in the area for cases diagnosed between January 1, 1970 and December 31, 2006.
RESULTS: In the 559 patients diagnosed, 1107 cases of asbestos-related diseases were identified. Between 2000 and 2006, the average annual incidence was 9.5 cases per 100,000 inhabitants for the entire study area and 35.5 cases per 100,000 for the area nearest the factory. The prevalence of asbestos-related diseases as of December 31, 2006 was 91 cases per 100,000 inhabitants in the entire study area and 353.4 cases per 100,000 in the area nearest the factory. Of the 1107 asbestos-related disease cases identified, 86.5% were benign and 8.4% pleural mesothelioma.
CONCLUSIONS: The factory introduced an important area-wide risk factor for asbestos-related diseases for both workers and for the nearby population. The number of cases of asbestos-related diseases detected annually showed an upward trend. The incidence was extremely high in the period studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501947     DOI: 10.1016/j.arbres.2009.04.007

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Prospective study of asbestos-related diseases incidence cases in primary health care in an area of Barcelona province.

Authors:  Magdalena Rosell-Murphy; Rafael Abós-Herràndiz; Josep Tarrés; Xavier Martínez-Artés; Isabel García-Allas; Ilona Krier; Gloria Cantarell; Miguel Gallego; Ramon Orriols; Constança Albertí
Journal:  BMC Public Health       Date:  2010-04-22       Impact factor: 3.295

2.  Compensation for Asbestos-Related Diseases in Japan: Utilization of Standard Classifications of Industry and Occupations

Authors:  Kittisak Sawanyawisuth; Sugio Furuya; Eun-Kee Park; Jun-Pyo Myong; Juan Pablo Ramos-Bonilla; Odgerel Chimed Ochir; Ken Takahashi
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

3.  Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis.

Authors:  Rafael Abós-Herràndiz; Teresa Rodriguez-Blanco; Isabel Garcia-Allas; Isabel-Magdalena Rosell-Murphy; Constança Albertí-Casas; Josep Tarrés; Illona Krier-Günther; Xavier Martinez-Artés; Ramon Orriols; Isidre Grimau-Malet; Jaume Canela-Soler
Journal:  Can Respir J       Date:  2017-06-07       Impact factor: 2.409

4.  Pleural plaques by inhalation of asbestos fibers.

Authors:  Diemen Delgado; Oscar Ramírez; Nayab Sultan; Patricio Miranda; Ashley Delgado
Journal:  Rev Bras Med Trab       Date:  2020-12-11

5.  Risk factors associated with asbestos-related diseases: a community-based case-control study.

Authors:  Magdalena-Isabel Rosell-Murphy; Rafael Abós-Herràndiz; Josep Tarrés Olivella; Constança Alberti-Casas; Isabel García Allas; Xavier Martinez Artés; Ilona Krier Günther; Isidre Grimau Malet; Ramon Orriols Martínez; Jaume Canela-Soler
Journal:  BMC Public Health       Date:  2013-08-06       Impact factor: 3.295

6.  Medical costs of asbestos-related diseases in Spain between 2004 and 2011.

Authors:  Montserrat García-Gómez; Rosa Urbanos Garrido; Rosario Castañeda López; Alfredo Menéndez-Navarro
Journal:  Ind Health       Date:  2016-06-23       Impact factor: 2.179

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.